Abstract
Objectives
To investigate pathological and oncological outcomes of obese patients who underwent robot-assisted radical prostatectomy (RARP) compared with laparoscopic radical prostatectomy (LRP) or open retropubic radical prostatectomy (RRP) since limited comparative data exist with regard to oncological and survival outcomes.
Methods
A total of 869 patients with body mass index ≥30 from two academic centers were identified. A total of 194 patients who underwent RARP were propensity score (PS) matched 1:1 to LRP or RRP cases. PS-matching variables included prostate-specific antigen (PSA), biopsy Gleason score, clinical stage, surgeon experience, and nerve-sparing technique. Predictors of positive surgical margins (PSMs) were analyzed using logistic regression. Predictors of recurrence-free survival (RFS) were analyzed within Cox regression models. Overall survival was compared with RFS using the log-rank test.
Results
Pathologic Gleason scores <7, =7, and >7 were found in 24.2, 63.6, and 11.7 % of patients, respectively. There were no statistically significant differences related to pathologic stage or lymph node metastases between surgical techniques. PSM for pT2 disease were observed in 22.9, 17.4, and 19.3 % of patients undergoing RARP, LRP, and RRP, respectively (not significantly different). Preoperative PSA and clinical stage cT2 disease were independently associated with PSM. There were no significant differences in mean 3-year RFS for RARP, LRP, and RRP (87.4, 91.0, and 85.7 %). Biopsy Gleason score >7, PSM, and clinical stage two were independent predictors of decreased RFS.
Conclusions
RARP demonstrates similar pathological and oncological results compared with LRP or RRP for obese patients.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- RP:
-
Radical prostatectomy
- RRP:
-
Retropubic RP
- LRP:
-
Laparoscopic RP
- RARP:
-
Robot-assisted RP
- PSA:
-
Prostate-specific antigen
- PSM:
-
Positive surgical margin
- PS:
-
Propensity score
- BCR:
-
Biochemical recurrence
- RFS:
-
Recurrence-free survival
- OS:
-
Overall survival
References
Center MM, Jemal A, Lortet-Tieulent J et al (2012) International variation in prostate cancer incidence and mortality rates. Eur Urol 61(6):1079–1092
Steiner MS (1995) Current results and patient selection for nerve-sparing radical retropubic prostatectomy. Semin Urol Oncol 13(3):204–214
Walsh PC (1988) Nerve sparing radical prostatectomy for early stage prostate cancer. Semin Oncol 15(4):351–358
Zorn KC, Gofrit ON, Orvieto MA et al (2007) Da Vinci robot error and failure rates: single institution experience on a single three-arm robot unit of more than 700 consecutive robot-assisted laparoscopic radical prostatectomies. J Endourol 21(11):1341–1344
Trinh QD, Sammon J, Sun M et al (2012) Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample. Eur Urol 61(4):679–685
Berryhill R Jr, Jhaveri J, Yadav R et al (2008) Robotic prostatectomy: a review of outcomes compared with laparoscopic and open approaches. Urology 72(1):15–23
Ramanathan R, Salamanca JI, Mandhani A et al (2009) Does 3-dimensional (3-D) visualization improve the quality of assistance during robotic radical prostatectomy? World J Urol 27(1):95–99
Mikhail AA, Stockton BR, Orvieto MA et al (2006) Robotic-assisted laparoscopic prostatectomy in overweight and obese patients. Urology 67(4):774–779
Ahlering TE, Eichel L, Edwards R et al (2005) Impact of obesity on clinical outcomes in robotic prostatectomy. Urology 65(4):740–744
Bae JJ, Choi SH, Kwon TG et al (2012) Advantages of robot-assisted laparoscopic radical prostatectomy in obese patients: comparison with the open procedure. Korean J Urol 53(8):536–540
Pfitzenmaier J, Pahernik S, Tremmel T et al (2008) Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression? BJU Int 102(10):1413–1418
Ficarra V, Novara G, Artibani W et al (2009) Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol 55(5):1037–1063
Hu JC, Gu X, Lipsitz SR et al (2009) Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA 302(14):1557–1564
Hu JC, Wang Q, Pashos CL et al (2008) Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol 26(14):2278–2284
Flegal KM, Carroll MD, Ogden CL et al (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303(3):235–241
Chang SS, Duong DT, Wells N et al (2004) Predicting blood loss and transfusion requirements during radical prostatectomy: the significant negative impact of increasing body mass index. J Urol 171(5):1861–1865
Lee SE, Lee WK, Jeong MS et al (2011) Is body mass index associated with pathological outcomes after radical prostatectomy in Korean men? BJU Int 107(8):1250–1255
Boorjian SA, Crispen PL, Carlson RE et al (2008) Impact of obesity on clinicopathologic outcomes after robot-assisted laparoscopic prostatectomy. J Endourol 22(7):1471–1476
Magheli A, Gonzalgo ML, Su LM et al (2011) Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching. BJU Int 107(12):1956–1962
Magheli A, Rais-Bahrami S, Trock BJ et al (2008) Impact of body mass index on biochemical recurrence rates after radical prostatectomy: an analysis utilizing propensity score matching. Urology 72(6):1246–1251
Allott EH, Masko EM, Freedland SJ (2013) Obesity and prostate cancer: weighing the evidence. Eur Urol 63(5):800–809
Ho T, Gerber L, Aronson WJ et al (2012) Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the search database. Eur Urol 62(5):910–916
Isbarn H, Jeldres C, Budaus L et al (2009) Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy series. Urology 73(3):615–619
Yates J, Munver R, Sawczuk I (2011) Robot-assisted laparoscopic radical prostatectomy in the morbidly obese patient. Prostate Cancer 2011:618623
Campeggi A, Xylinas E, Ploussard G et al (2012) Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy. Urology 80(3):576–584
Eden CG, Chang CM, Gianduzzo T et al (2006) The impact of obesity on laparoscopic radical prostatectomy. BJU Int 98(6):1279–1282
Acknowledgments
We acknowledge the excellent work of Markus Loos on the Charité prostate cancer database. This study was funded by a Charles Huggins-Grant of the German Society of Urology. Dr. Gonzalgo has served as a consultant to Intuitive Surgical.
Ethical standard
This study was approved by the review boards of both institutions (Stanford, Charité).
Author information
Authors and Affiliations
Corresponding author
Additional information
Jonas Busch, Mark L. Gonzalgo and Ahmed Magheli have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Busch, J., Gonzalgo, M.L., Leva, N. et al. Matched comparison of robot‐assisted, laparoscopic and open radical prostatectomy regarding pathologic and oncologic outcomes in obese patients. World J Urol 33, 397–402 (2015). https://doi.org/10.1007/s00345-014-1326-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-014-1326-1